These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 15265851)

  • 1. Role of vitamin K2 in the development of hepatocellular carcinoma in women with viral cirrhosis of the liver.
    Habu D; Shiomi S; Tamori A; Takeda T; Tanaka T; Kubo S; Nishiguchi S
    JAMA; 2004 Jul; 292(3):358-61. PubMed ID: 15265851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of vitamin K2 on the development of hepatocellular carcinoma in type C cirrhosis.
    Kojima K; Tamano M; Akima T; Hashimoto T; Kuniyoshi T; Maeda C; Majima Y; Kusano K; Murohisa T; Iijima M; Hiraishi H
    Hepatogastroenterology; 2010; 57(102-103):1264-7. PubMed ID: 21410069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preventive effects of vitamin K on recurrent disease in patients with hepatocellular carcinoma arising from hepatitis C viral infection.
    Kakizaki S; Sohara N; Sato K; Suzuki H; Yanagisawa M; Nakajima H; Takagi H; Naganuma A; Otsuka T; Takahashi H; Hamada T; Mori M
    J Gastroenterol Hepatol; 2007 Apr; 22(4):518-22. PubMed ID: 17376044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colchicine delays the development of hepatocellular carcinoma in patients with hepatitis virus-related liver cirrhosis.
    Arrieta O; Rodriguez-Diaz JL; Rosas-Camargo V; Morales-Espinosa D; Ponce de Leon S; Kershenobich D; Leon-Rodriguez E
    Cancer; 2006 Oct; 107(8):1852-8. PubMed ID: 16967451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin K2 (menatetrenone) for bone loss in patients with cirrhosis of the liver.
    Shiomi S; Nishiguchi S; Kubo S; Tamori A; Habu D; Takeda T; Ochi H
    Am J Gastroenterol; 2002 Apr; 97(4):978-81. PubMed ID: 12003435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin K deficiency and hepatocellular carcinoma.
    Piquet MA; Hourmand-Ollivier I; Dao T
    JAMA; 2004 Dec; 292(21):2580-1; author reply 2581. PubMed ID: 15572713
    [No Abstract]   [Full Text] [Related]  

  • 7. Pilot clinical trial of the use of alpha-tocopherol for the prevention of hepatocellular carcinoma in patients with liver cirrhosis.
    Takagi H; Kakizaki S; Sohara N; Sato K; Tsukioka G; Tago Y; Konaka K; Kabeya K; Kaneko M; Takayama H; Hashimoto Y; Yamada T; Takahashi H; Shimojo H; Nagamine T; Mori M
    Int J Vitam Nutr Res; 2003 Nov; 73(6):411-5. PubMed ID: 14743544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon therapy does not prevent hepatocellular carcinoma in HCV compensated cirrhosis.
    Testino G; Ansaldi F; Andorno E; Ravetti GL; Ferro C; De Iaco F; Icardi G; Valente U
    Hepatogastroenterology; 2002; 49(48):1636-8. PubMed ID: 12397752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of vitamin K2 on the recurrence of hepatocellular carcinoma.
    Yoshida H; Shiratori Y; Kudo M; Shiina S; Mizuta T; Kojiro M; Yamamoto K; Koike Y; Saito K; Koyanagi N; Kawabe T; Kawazoe S; Kobashi H; Kasugai H; Osaki Y; Araki Y; Izumi N; Oka H; Tsuji K; Toyota J; Seki T; Osawa T; Masaki N; Ichinose M; Seike M; Ishikawa A; Ueno Y; Tagawa K; Kuromatsu R; Sakisaka S; Ikeda H; Kuroda H; Kokuryu H; Yamashita T; Sakaida I; Katamoto T; Kikuchi K; Nomoto M; Omata M
    Hepatology; 2011 Aug; 54(2):532-40. PubMed ID: 21574174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Varying incidence of cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis C responding differently to interferon therapy.
    Shindo M; Ken A; Okuno T
    Cancer; 1999 May; 85(9):1943-50. PubMed ID: 10223234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of vitamin K2 on the recurrence in patients with hepatocellular carcinoma.
    Hotta N; Ayada M; Sato K; Ishikawa T; Okumura A; Matsumoto E; Ohashi T; Kakumu S
    Hepatogastroenterology; 2007; 54(79):2073-7. PubMed ID: 18251162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term evaluation of interferon therapy in hepatitis C virus-associated cirrhosis: does IFN prevent development of hepatocellular carcinoma?
    Tanaka K; Sata M; Uchimura Y; Suzuki H; Tanikawa K
    Oncol Rep; 1998; 5(1):205-8. PubMed ID: 9458323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of virological response to entecavir on the development of hepatocellular carcinoma in hepatitis B viral cirrhotic patients: comparison between compensated and decompensated cirrhosis.
    Kim SS; Hwang JC; Lim SG; Ahn SJ; Cheong JY; Cho SW
    Am J Gastroenterol; 2014 Aug; 109(8):1223-33. PubMed ID: 24890440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significant reduction in end-stage liver diseases burden through the national viral hepatitis therapy program in Taiwan.
    Chiang CJ; Yang YW; Chen JD; You SL; Yang HI; Lee MH; Lai MS; Chen CJ
    Hepatology; 2015 Apr; 61(4):1154-62. PubMed ID: 25476749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ursodiol use is possibly associated with lower incidence of hepatocellular carcinoma in hepatitis C virus-associated liver cirrhosis.
    Tarao K; Fujiyama S; Ohkawa S; Miyakawa K; Tamai S; Hirokawa S; Masaki T; Tanaka K
    Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):164-9. PubMed ID: 15668491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level.
    Chen CJ; Yang HI; Su J; Jen CL; You SL; Lu SN; Huang GT; Iloeje UH;
    JAMA; 2006 Jan; 295(1):65-73. PubMed ID: 16391218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Vitamin K2 as a protector of bone health and beyond].
    Kaneki M
    Clin Calcium; 2005 Apr; 15(4):605-10. PubMed ID: 15802772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Viral liver cirrhosis: natural course, pathogenesis and clinical implications of the complications].
    Gentilini P; Laffi G; La Villa G; Casini-Raggi V; Romanelli RG; Buzzelli G; Mazzanti R; Marra F; Pinzani M; Zignego AL
    Ann Ital Med Int; 1996 Oct; 11 Suppl 2():23S-29S. PubMed ID: 9004817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.
    Chiaramonte M; Stroffolini T; Vian A; Stazi MA; Floreani A; Lorenzoni U; Lobello S; Farinati F; Naccarato R
    Cancer; 1999 May; 85(10):2132-7. PubMed ID: 10326690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hepatocellular carcinoma and vitamin K2].
    Mizuta T; Ozaki I
    Clin Calcium; 2015 Nov; 25(11):1645-51. PubMed ID: 26503869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.